Breaking News

QSV To Manufacture Protein for Clinical Trial

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

QSV Biologics, Ltd. has signed a cGMP manufacturing contract with a California-based biopharmaceutical company. The recombinant therapeutic protein manufactured by QSV will be used in upcoming clinical studies. QSV will be responsible for technology transfer and cGMP manufacture of the clinical trial material at its cGMP manufacturing facility in Edmonton. Details of the agreement have not been disclosed. Graeme Macaloney Ph.D., PEng, QSV president and chief executive officer said, “We a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters